Alfurayh O - Search Results

1

Histologically advanced chronic hepatitis C treated with recombinant alpha-interferon: a randomized placebo-controlled double-blind cross-over study.

Sieck JO, Ellis ME, Alfurayh O, Ali MA, Ali HA, Ayub A, al-Fadda M, Zafar M, Halim M, Bernvil SS, et al. Sieck JO, et al. Among authors: alfurayh o. J Hepatol. 1993 Nov;19(3):418-23. doi: 10.1016/s0168-8278(05)80552-5. J Hepatol. 1993. PMID: 7512110 Clinical Trial.

2

Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha.

Ellis ME, Alfurayh O, Halim MA, Sieck JO, Ali MA, Bernvil SS, Ali H, Barri Y, Ayub A, al-Fadda M. Ellis ME, et al. Among authors: alfurayh o. J Hepatol. 1993 Jun;18(2):210-6. doi: 10.1016/s0168-8278(05)80248-x. J Hepatol. 1993. PMID: 8409337 Clinical Trial.

3

Impact of hepatitis C virus infection on kidney transplant outcome.

Alfurayh OI, Sobh MA, Chaudry TS, Qunibi WY, Al Meshari K, Ellis M, Ali MA, Taher S. Alfurayh OI, et al. Saudi J Kidney Dis Transpl. 1995 April-June;6(2):183-9. Saudi J Kidney Dis Transpl. 1995. PMID: 18583862

4

Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study.

Alfurayh O, Sobh M, Buali A, Ali MA, Barri Y, Qunibi W, Taher S. Alfurayh O, et al. Nephrol Dial Transplant. 1992;7(4):327-32. doi: 10.1093/oxfordjournals.ndt.a092137. Nephrol Dial Transplant. 1992. PMID: 1375712

5

Hepatitis C Virus Infection in a Hemodialysis and Kidney Transplant Patient: An Eight Year Follow-up Report.

Al Meshari K, Abutaleb N, Alfurayh OI, Ali MA. Al Meshari K, et al. Among authors: alfurayh oi. Saudi J Kidney Dis Transpl. 1995 April-June;6(2):211-5. Saudi J Kidney Dis Transpl. 1995. PMID: 18583866

6

Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.

Halim MA, Alfurayh O, Kalin ME, Dammas S, al-Eisa A, Damanhouri G. Halim MA, et al. Among authors: alfurayh o. Clin Infect Dis. 1993 Mar;16(3):397-9. doi: 10.1093/clind/16.3.397. Clin Infect Dis. 1993. PMID: 8135901

7

Hepatitis C virus infection in hemodialysis patients: comparison of two new hepatitis C antibody assays with a second-generation assay.

al Meshari K, Alfurayh O, Al Ahdal M, Qunibi W, Kessie G, De Vol E. al Meshari K, et al. Among authors: alfurayh o. J Am Soc Nephrol. 1995 Nov;6(5):1439-44. doi: 10.1681/ASN.V651439. J Am Soc Nephrol. 1995. PMID: 8589320

8

Aluminium overload and response to recombinant human erythropoietin in patients under chronic haemodialysis.

Alfurayh O, Sobh M, Barri Y, Qunibi W, Taher S. Alfurayh O, et al. Nephrol Dial Transplant. 1992;7(9):939-43. doi: 10.1093/ndt/7.9.939. Nephrol Dial Transplant. 1992. PMID: 1328942

9

Effect of liver disease in kidney transplant recipients on cyclosporine dose and metabolite levels.

Alfurayh O, Sobh M, Minhas M, Almeshari K, Alshaibani K, Qunibi W, Aesha H, Taher S. Alfurayh O, et al. Transplant Proc. 1994 Oct;26(5):2655. Transplant Proc. 1994. PMID: 7940830 Clinical Trial. No abstract available.

10

New insights into hepatitis C virus infection of hemodialysis patients: the implications.

al Meshari K, al Ahdal M, Alfurayh O, Ali A, De Vol E, Kessie G. al Meshari K, et al. Among authors: alfurayh o. Am J Kidney Dis. 1995 Apr;25(4):572-8. doi: 10.1016/0272-6386(95)90125-6. Am J Kidney Dis. 1995. PMID: 7702052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters